2014 Form 10-K Financial Statement
#000114420415017897 Filed on March 24, 2015
Income Statement
Concept | 2014 | 2013 Q4 | 2013 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $3.700M | $1.410M | $4.440M |
YoY Change | -16.67% | 50.0% | 22.31% |
% of Gross Profit | |||
Research & Development | $5.964M | $1.550M | $6.860M |
YoY Change | -13.06% | 26.02% | 33.92% |
% of Gross Profit | |||
Depreciation & Amortization | $367.2K | $90.00K | $424.8K |
YoY Change | -13.55% | -25.0% | -14.58% |
% of Gross Profit | |||
Operating Expenses | $5.964M | $2.960M | $6.860M |
YoY Change | -13.06% | 37.04% | 33.92% |
Operating Profit | -$9.891M | -$12.40M | |
YoY Change | -20.25% | 41.66% | |
Interest Expense | -$446.3K | $110.0K | -$9.348K |
YoY Change | 4674.43% | 1000.0% | 12.15% |
% of Operating Profit | |||
Other Income/Expense, Net | $1.839M | $0.00 | $1.620M |
YoY Change | 13.53% | -3939.0% | |
Pretax Income | -$8.050M | -$3.950M | -$10.78M |
YoY Change | -25.32% | 82.87% | 22.5% |
Income Tax | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | |||
Net Earnings | -$8.052M | -$3.950M | -$10.78M |
YoY Change | -25.32% | 82.87% | 22.57% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$161.0M | -$131.7M | -$359.3M |
COMMON SHARES | |||
Basic Shares Outstanding | 57.40M shares | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2014 | 2013 Q4 | 2013 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $9.420M | $2.420M | $2.420M |
YoY Change | 289.26% | -48.29% | -48.29% |
Cash & Equivalents | $9.420M | $2.418M | $2.420M |
Short-Term Investments | |||
Other Short-Term Assets | $280.0K | $350.0K | $350.0K |
YoY Change | -20.0% | -23.91% | -23.91% |
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $9.700M | $2.768M | $2.770M |
YoY Change | 250.18% | -46.05% | -46.0% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $2.030M | $2.361M | $2.360M |
YoY Change | -13.98% | -10.75% | -10.94% |
Goodwill | $1.675M | ||
YoY Change | 0.0% | ||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $10.00K | $11.87K | $10.00K |
YoY Change | 0.0% | -56.39% | -99.51% |
Total Long-Term Assets | $3.720M | $4.048M | $4.050M |
YoY Change | -8.15% | -36.23% | -36.22% |
TOTAL ASSETS | |||
Total Short-Term Assets | $9.700M | $2.768M | $2.770M |
Total Long-Term Assets | $3.720M | $4.048M | $4.050M |
Total Assets | $13.42M | $6.816M | $6.820M |
YoY Change | 96.77% | -40.62% | -40.59% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $930.0K | $1.160M | $1.160M |
YoY Change | -19.83% | 61.11% | 61.11% |
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $120.0K | $0.00 | $0.00 |
YoY Change | |||
Total Short-Term Liabilities | $6.230M | $4.523M | $4.520M |
YoY Change | 37.83% | 517.33% | 519.18% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $340.0K | $450.0K | $450.0K |
YoY Change | -24.44% | 0.0% | 0.0% |
Other Long-Term Liabilities | $150.0K | $140.0K | $140.0K |
YoY Change | 7.14% | 0.0% | 0.0% |
Total Long-Term Liabilities | $490.0K | $593.2K | $590.0K |
YoY Change | -16.95% | 1.05% | 0.0% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $6.230M | $4.523M | $4.520M |
Total Long-Term Liabilities | $490.0K | $593.2K | $590.0K |
Total Liabilities | $6.720M | $5.116M | $5.120M |
YoY Change | 31.25% | 287.67% | 287.88% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$51.06M | ||
YoY Change | |||
Common Stock | $29.00 | ||
YoY Change | -93.75% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $6.700M | $1.700M | $1.700M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $13.42M | $6.816M | $6.820M |
YoY Change | 96.77% | -40.62% | -40.59% |
Cashflow Statement
Concept | 2014 | 2013 Q4 | 2013 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$8.052M | -$3.950M | -$10.78M |
YoY Change | -25.32% | 82.87% | 22.57% |
Depreciation, Depletion And Amortization | $367.2K | $90.00K | $424.8K |
YoY Change | -13.55% | -25.0% | -14.58% |
Cash From Operating Activities | -$8.840M | -$2.670M | -$9.150M |
YoY Change | -3.39% | 57.06% | 38.85% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $29.57K | -$20.00K | $147.8K |
YoY Change | -80.0% | -66.67% | 51.31% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $0.00 | $2.000M |
YoY Change | -100.0% | -100.0% | -200.0% |
Cash From Investing Activities | -$30.00K | -$20.00K | $1.850M |
YoY Change | -101.62% | -99.03% | -188.1% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $12.40M | -$4.975M | |
YoY Change | -349.16% | -27.25% | |
Debt Paid & Issued, Net | $0.00 | ||
YoY Change | |||
Cash From Financing Activities | 15.87M | 0.000 | 5.040M |
YoY Change | 214.88% | -100.0% | -35.8% |
NET CHANGE | |||
Cash From Operating Activities | -8.840M | -2.670M | -9.150M |
Cash From Investing Activities | -30.00K | -20.00K | 1.850M |
Cash From Financing Activities | 15.87M | 0.000 | 5.040M |
Net Change In Cash | 7.000M | -2.690M | -2.260M |
YoY Change | -409.73% | 189.25% | 169.05% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$8.840M | -$2.670M | -$9.150M |
Capital Expenditures | $29.57K | -$20.00K | $147.8K |
Free Cash Flow | -$8.870M | -$2.650M | -$9.298M |
YoY Change | -4.61% | 61.59% | 39.03% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2014Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2184590 | USD |
CY2014Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
1128499 | USD |
CY2014Q4 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
2180 | USD |
CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4523155 | USD |
CY2014Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
933988 | USD |
CY2013Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1162098 | USD |
CY2013Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
3359363 | USD |
CY2013Q4 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
1694 | USD |
CY2013Q4 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
0 | USD |
CY2013Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
143234 | USD |
CY2014Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
488977 | USD |
CY2014Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
147774 | USD |
CY2014Q4 | us-gaap |
Liabilities
Liabilities
|
2673567 | USD |
CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
5116389 | USD |
CY2014Q4 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
11126 | USD |
CY2014Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
69911836 | USD |
CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1699550 | USD |
CY2014Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
76 | USD |
CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
52759089 | USD |
CY2014Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-51059568 | USD |
CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
6815939 | USD |
CY2014Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-59165963 | USD |
CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10745949 | USD |
CY2014Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
13419516 | USD |
CY2013Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2013Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
294687 | USD |
CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9422627 | USD |
CY2014Q4 | us-gaap |
Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
|
55000 | USD |
CY2014Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
220611 | USD |
CY2014Q4 | us-gaap |
Assets Current
AssetsCurrent
|
9698238 | USD |
CY2014Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2033944 | USD |
CY2014Q4 | us-gaap |
Goodwill
Goodwill
|
1675462 | USD |
CY2014Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
11872 | USD |
CY2014Q4 | us-gaap |
Assets
Assets
|
13419516 | USD |
CY2014Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
330077 | USD |
CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
29 | USD |
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2418384 | USD |
CY2013Q4 | us-gaap |
Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
|
55000 | USD |
CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
2768071 | USD |
CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2360534 | USD |
CY2013Q4 | us-gaap |
Goodwill
Goodwill
|
1675462 | USD |
CY2013Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
11872 | USD |
CY2013Q4 | us-gaap |
Assets
Assets
|
6815939 | USD |
CY2013Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
0 | USD |
CY2014Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
119923 | USD |
CY2013Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
450000 | USD |
CY2013Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
593234 | USD |
CY2014Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
333907 | shares |
CY2014Q4 | clrb |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Unvested Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsUnvestedOutstandingNumber
|
385559 | shares |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
333907 | shares |
CY2013 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4444767 | USD |
CY2014 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3704676 | USD |
CY2014 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
9890945 | USD |
CY2014 | us-gaap |
Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
|
1 | pure |
CY2013 | us-gaap |
Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
|
P3Y10M20D | |
CY2014 | us-gaap |
Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
|
P3Y1M20D | |
CY2014Q1 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
275000 | shares |
CY2014Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
6604096 | shares |
CY2014 | us-gaap |
Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
|
0.0107 | pure |
CY2013 | us-gaap |
Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
|
1.15 | pure |
CY2013 | us-gaap |
Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
|
0.0263 | pure |
CY2013Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.00001 | |
CY2014Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.00001 | |
CY2013Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
7000 | shares |
CY2014Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
7000 | shares |
CY2013Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2014Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2013Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2014Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
CY2014Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
20000000 | shares |
CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
20000000 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2869739 | shares |
CY2014Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7562762 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2869739 | shares |
CY2014Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7562762 | shares |
CY2014Q3 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
13475832 | USD |
CY2014Q3 | us-gaap |
Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
|
11877143 | USD |
CY2014Q3 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
1598689 | USD |
CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2323233 | USD |
CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
850350 | USD |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.09 | pure |
CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
9.20 | |
CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
3.69 | |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
5.60 | |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.01 | |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
321959 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
634658 | shares |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
344278 | shares |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
120300 | shares |
CY2013 | clrb |
Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
|
9452 | shares |
CY2014 | clrb |
Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
|
18437 | shares |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
22127 | shares |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
17055 | shares |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
719466 | shares |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
30.40 | |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
18.07 | |
CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
9.20 | |
CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
3.69 | |
CY2013 | clrb |
Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice
|
117.80 | |
CY2014 | clrb |
Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice
|
24.19 | |
CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
15.60 | |
CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
14.58 | |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
15.59 | |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
24.53 | |
CY2014Q4 | clrb |
Share Based Compensation Arrangement By Share Based Payment Award Options Non Vested Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedExercisableWeightedAverageExercisePrice
|
7.85 | |
CY2014Q4 | clrb |
Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingAggregateIntrinsicValue
|
17500 | USD |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
0 | USD |
CY2014Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
0 | USD |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
81805 | shares |
CY2014 | clrb |
Employee Service Share Based Compensation Nonvested Total Compensation In Current Year
EmployeeServiceShareBasedCompensationNonvestedTotalCompensationInCurrentYear
|
615754 | USD |
CY2014 | clrb |
Employee Service Share Based Compensation Nonvested Total Compensation In Year Two
EmployeeServiceShareBasedCompensationNonvestedTotalCompensationInYearTwo
|
455975 | USD |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
24.53 | |
CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P4Y7M10D | |
CY2014 | clrb |
Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingWeightedAverageRemainingContractualTerm
|
P9Y1M2D | |
CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P4Y7M10D | |
CY2014 | clrb |
Employee Service Share Based Compensation Nonvested Total Compensation In Year Three
EmployeeServiceShareBasedCompensationNonvestedTotalCompensationInYearThree
|
265240 | USD |
CY2014Q4 | clrb |
Share Based Compensation Arrangement By Sharebased Payment Award Options Unvested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedAndExpectedToVestOutstandingNumber
|
253754 | shares |
CY2014 | clrb |
Estimated Stock Based Compensation Expense Up On Vesting Of Options
EstimatedStockBasedCompensationExpenseUpOnVestingOfOptions
|
418024 | USD |
CY2014Q1 | clrb |
Antidilution Option Reduced By Expiration Of Warrants
AntidilutionOptionReducedByExpirationOfWarrants
|
14474 | shares |
CY2014Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
10.00 | |
CY2013Q4 | clrb |
Antidilution Option Reduced Rate
AntidilutionOptionReducedRate
|
19 | shares |
CY2014Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
1754993 | USD |
CY2014 | us-gaap |
Severance Costs1
SeveranceCosts1
|
160000 | USD |
CY2013 | clrb |
Payment Towards Clinical Trial Agreements
PaymentTowardsClinicalTrialAgreements
|
380625 | USD |
CY2014 | clrb |
Payment Towards Clinical Trial Agreements
PaymentTowardsClinicalTrialAgreements
|
508000 | USD |
CY2013 | us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
187500 | USD |
CY2013 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
6860163 | USD |
CY2014 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5964453 | USD |
CY2013 | us-gaap |
Restructuring Costs
RestructuringCosts
|
1096874 | USD |
CY2014 | us-gaap |
Restructuring Costs
RestructuringCosts
|
221816 | USD |
CY2013 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
12401804 | USD |
CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-12401804 | USD |
CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9890945 | USD |
CY2013 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
2373941 | USD |
CY2014 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
2230864 | USD |
CY2013 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-744957 | USD |
CY2014 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
0 | USD |
CY2013 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-9348 | USD |
CY2014 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-446314 | USD |
CY2013 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1619636 | USD |
CY2014 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1784550 | USD |
CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10782168 | USD |
CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8106395 | USD |
CY2013 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-3.86 | |
CY2014 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.77 | |
CY2013 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
2794557 | shares |
CY2014 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
4592657 | shares |
CY2013 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
424758 | USD |
CY2014 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
367197 | USD |
CY2013 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
0 | USD |
CY2014 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
426458 | USD |
CY2013 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-7523 | USD |
CY2014 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-2269 | USD |
CY2013 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
445108 | USD |
CY2014 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-228110 | USD |
CY2013 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-48056 | USD |
CY2014 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-74076 | USD |
CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-9154644 | USD |
CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-8840479 | USD |
CY2013 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
147812 | USD |
CY2014 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
29569 | USD |
CY2013 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
-2000000 | USD |
CY2014 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
0 | USD |
CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
1852188 | USD |
CY2014 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-29569 | USD |
CY2013 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
0 | USD |
CY2014 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
4000000 | USD |
CY2013 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
0 | USD |
CY2014 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
617500 | USD |
CY2013 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | USD |
CY2014 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
617500 | USD |
CY2013 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
2397 | USD |
CY2014 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
1694 | USD |
CY2013 | clrb |
Reverse Stock Split Fractional Shares
ReverseStockSplitFractionalShares
|
0 | USD |
CY2014 | clrb |
Reverse Stock Split Fractional Shares
ReverseStockSplitFractionalShares
|
1158 | USD |
CY2013 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
4975153 | USD |
CY2014 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
12395965 | USD |
CY2013 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
0 | USD |
CY2014 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
518822 | USD |
CY2013 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
70539 | USD |
CY2014 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
0 | USD |
CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
5043295 | USD |
CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
15874291 | USD |
CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-2259161 | USD |
CY2014 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
7004243 | USD |
CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4677545 | USD |
CY2013 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
0 | USD |
CY2014 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
4172435 | USD |
CY2013 | clrb |
Fair Value Of Warrants Classified As Derivative Liability
FairValueOfWarrantsClassifiedAsDerivativeLiability
|
5720000 | USD |
CY2014 | clrb |
Fair Value Of Warrants Classified As Derivative Liability
FairValueOfWarrantsClassifiedAsDerivativeLiability
|
0 | USD |
CY2013 | clrb |
Debt Conversion Converted Instrument Value Warrants Issued
DebtConversionConvertedInstrumentValueWarrantsIssued
|
0 | USD |
CY2014 | clrb |
Debt Conversion Converted Instrument Value Warrants Issued
DebtConversionConvertedInstrumentValueWarrantsIssued
|
254024 | USD |
CY2013 | us-gaap |
Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
|
7830 | USD |
CY2014 | us-gaap |
Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
|
4540 | USD |
CY2013 | us-gaap |
Interest Paid
InterestPaid
|
0 | USD |
CY2014 | us-gaap |
Interest Paid
InterestPaid
|
3156 | USD |
CY2013 | us-gaap |
Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
|
0 | USD |
CY2014 | us-gaap |
Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
|
13306 | USD |
CY2014 | dei |
Document Type
DocumentType
|
10-K | |
CY2014 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2014 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-12-31 | |
CY2014 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | |
CY2014 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2014 | dei |
Entity Registrant Name
EntityRegistrantName
|
Cellectar Biosciences, Inc. | |
CY2014 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001279704 | |
CY2014 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2014 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2014 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2014 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2014 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
CY2014Q2 | dei |
Entity Public Float
EntityPublicFloat
|
12793777 | USD |
CY2014 | dei |
Trading Symbol
TradingSymbol
|
CLRB | |
CY2015Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
7562762 | shares |
CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
5625482 | USD |
CY2014Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
5646058 | USD |
CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3264948 | USD |
CY2014Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3612114 | USD |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
112657 | shares |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
|
136022 | USD |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
|
171835 | USD |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
|
569496 | USD |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
|
47853 | USD |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
|
101972 | USD |
CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
2109200 | USD |
CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
936310 | USD |
CY2014Q4 | clrb |
Deferred Tax Assets Tax Credit Carry Forwards Domestic Research And Development
DeferredTaxAssetsTaxCreditCarryForwardsDomesticResearchAndDevelopment
|
2689775 | USD |
CY2013 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
CY2014 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
CY2013 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
CY2014 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
CY2013 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
0 | USD |
CY2014 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
0 | USD |
CY2013 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-4705250 | USD |
CY2014 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-3868524 | USD |
CY2013 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
134225 | USD |
CY2014 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
810914 | USD |
CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10158375 | USD |
CY2013 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
4975153 | USD |
CY2014 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
11877143 | USD |
CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2323233 | USD |
CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
850350 | USD |
CY2013 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-4571025 | USD |
CY2014 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-3057610 | USD |
CY2013 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
4571025 | USD |
CY2014 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
3057610 | USD |
CY2013 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2014 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
25731718 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
29246965 | USD |
CY2013Q4 | clrb |
Deferred Tax Assets Tax Credit Carry Forwards Domestic Research And Development
DeferredTaxAssetsTaxCreditCarryForwardsDomesticResearchAndDevelopment
|
2480417 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
2070642 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
1813954 | USD |
CY2013Q4 | clrb |
Deferred Tax Assets Tax Credit Carry Forwards State And Local Research And Development
DeferredTaxAssetsTaxCreditCarryForwardsStateAndLocalResearchAndDevelopment
|
724200 | USD |
CY2014Q4 | clrb |
Deferred Tax Assets Tax Credit Carry Forwards State And Local Research And Development
DeferredTaxAssetsTaxCreditCarryForwardsStateAndLocalResearchAndDevelopment
|
753818 | USD |
CY2013Q4 | clrb |
Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs
DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts
|
11128803 | USD |
CY2014Q4 | clrb |
Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs
DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts
|
10609942 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
1599005 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
1758909 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
380339 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
313412 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
|
34850 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
|
0 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
26112 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
35392 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
44176086 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
47222167 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
257314 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
245785 | USD |
CY2013Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
257314 | USD |
CY2014Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
245785 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
43918772 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
46976382 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
43918772 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
46976382 | USD |
CY2013Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
CY2014Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
CY2014Q1 | clrb |
Convertible Debentures And Warrants To Purchase Common Stock
ConvertibleDebenturesAndWarrantsToPurchaseCommonStock
|
400000 | shares |
CY2013Q4 | us-gaap |
Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
|
55000 | USD |
CY2014Q4 | us-gaap |
Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
|
55000 | USD |
CY2014Q1 | clrb |
Payment For Convertible Debentures
PaymentForConvertibleDebentures
|
4000000 | USD |
CY2014 | us-gaap |
Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
|
P5Y | |
CY2014 | clrb |
Lease Term
LeaseTerm
|
P3Y | |
CY2013Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
|
826365 | shares |
CY2014Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
|
551365 | shares |
CY2014Q4 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
9173000 | USD |
CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
130000 | USD |
CY2014 | us-gaap |
Interest Expense Long Term Debt
InterestExpenseLongTermDebt
|
17000 | USD |
CY2014Q1 | us-gaap |
Convertible Debt
ConvertibleDebt
|
4000000 | USD |
CY2014 | us-gaap |
Debt Instrument Interest Rate Stated Percentage Rate Range Minimum
DebtInstrumentInterestRateStatedPercentageRateRangeMinimum
|
0.12 | pure |
CY2010Q3 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
450000 | USD |
CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
88000 | USD |
CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
0 | USD |
CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
0 | USD |
CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
218000 | USD |
CY2013 | us-gaap |
Interest Expense Long Term Debt
InterestExpenseLongTermDebt
|
9000 | USD |
CY2010 | clrb |
Interest And Principal Payments Period
InterestAndPrincipalPaymentsPeriod
|
2015-04-30 | |
CY2014 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></b> <font style="FONT-SIZE: 10pt">— The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and judgments that may affect the reported amounts of assets, liabilities, revenue and expenses and disclosure of contingent assets and liabilities. On an on-going basis, management evaluates its estimates including those related to unbilled vendor amounts and share-based compensation. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from those estimates under different assumptions or conditions. Changes in estimates are reflected in reported results in the period in which they become known.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2014 | clrb |
Unpaid Principal And Interest Description
UnpaidPrincipalAndInterestDescription
|
Monthly payments of $20,665 for principal and interest commence on May 1, 2015 and continue for 23 equal installments with the final installment of any remaining unpaid principal and interest due on April 1, 2017. | |
CY2014Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
119923 | USD |
CY2014Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
243590 | USD |
CY2014Q4 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
86487 | USD |
CY2014Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
450000 | USD |
CY2007 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
8050 | USD |
CY2013 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
229000 | USD |
CY2014 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
180000 | USD |
CY2014 | clrb |
Lease Rent Expansion Space
LeaseRentExpansionSpace
|
1140 | USD |
CY2014Q4 | clrb |
Expansion Space For Lease
ExpansionSpaceForLease
|
3400 | sqft |
CY2014 | clrb |
Lease Rent Escalation Percentage
LeaseRentEscalationPercentage
|
0.03 | pure |
CY2014 | clrb |
Maximum Renovation Expense
MaximumRenovationExpense
|
55000 | USD |
CY2013 | clrb |
Number Of Shares Reserved For Future Issuance
NumberOfSharesReservedForFutureIssuance
|
2473781 | shares |
CY2014 | clrb |
Number Of Shares Reserved For Future Issuance
NumberOfSharesReservedForFutureIssuance
|
7323562 | shares |
CY2003Q3 | clrb |
Payment Of License Fee
PaymentOfLicenseFee
|
10000 | USD |
CY2003Q3 | clrb |
Payment Of Sublicense Fee Description
PaymentOfSublicenseFeeDescription
|
if the sublicense fee payable to the Company is between 4% and 5% of net sales, then the royalties payable to U. Mich. Shall be equal to 50% of the sublicense fee. | |
CY2003Q3 | clrb |
Percentage Of Revenue Received In Kind
PercentageOfRevenueReceivedInKind
|
0.1 | pure |
CY2014 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">Concentration of Credit Risk</font></i></b> <font style="FONT-SIZE: 10pt">— Financial instruments that subject the Company to credit risk consist of cash and equivalents on deposit with financial institutions. The Company’s excess cash as of December 31, 2014 and 2013 is on deposit in a non-interest-bearing transaction account with a well-established financial institution. At times, such amounts may exceed the FDIC insurance limits. As of December 31, 2014, uninsured cash balances totaled approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9,173,000</font>.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2014 | clrb |
Resale Of Shares Of Common Stock
ResaleOfSharesOfCommonStock
|
200000 | shares |
CY2013Q4 | clrb |
Warrants Issued To Purchase Common Stock
WarrantsIssuedToPurchaseCommonStock
|
275000 | shares |
CY2013Q4 | clrb |
Fair Value Of Warrants Classified As Derivative Liability Outstanding
FairValueOfWarrantsClassifiedAsDerivativeLiabilityOutstanding
|
5720000 | USD |
CY2013 | clrb |
Change In Unrealized Gain Loss On Fair Value
ChangeInUnrealizedGainLossOnFairValue
|
2365000 | USD |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.3400 | pure |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.3400 | pure |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0082 | pure |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0660 | pure |
CY2013 | clrb |
Effective Income Tax Rate Reconciliation Permanent Adjustment
EffectiveIncomeTaxRateReconciliationPermanentAdjustment
|
0.0510 | pure |
CY2014 | clrb |
Effective Income Tax Rate Reconciliation Permanent Adjustment
EffectiveIncomeTaxRateReconciliationPermanentAdjustment
|
0.0933 | pure |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.4240 | pure |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.3772 | pure |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.0412 | pure |
CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.0099 | pure |
CY2013 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
CY2014 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
CY2013 | clrb |
Adjustments To Additional Paid In Capital Warrants Issued Sale Of Common Stock
AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedSaleOfCommonStock
|
4975043 | USD |
CY2014Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
550000 | shares |
CY2014 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
2227500 | USD |
CY2014 | clrb |
Stock And Warrants Issued Value To Extinguish Convertible Debentures
StockAndWarrantsIssuedValueToExtinguishConvertibleDebentures
|
4172435 | USD |
CY2014Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2014Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
20000000 | shares |
CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
254024 | USD |
CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
|
1158 | USD |
CY2014Q2 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
At the annual meeting of stockholders held on May 22, 2014, the Company’s stockholders approved an amendment to the certificate of incorporation to effect a reverse split of the Company’s common stock at a ratio between 1:10 to 1:20 in order to satisfy requirements for the listing of the Company’s common stock on the NASDAQ Capital Market. In addition, the proposal approved by the stockholders provided that if the reverse split was effected, the number of shares of common stock that the Company is authorized to issue would be reduced from 150,000,000 to the greater of (A) 20,000,000 and (B) the number of shares equal to three (3) times the sum of the number of all shares of common stock outstanding and the number of shares of common stock issuable upon exercise or conversion of all outstanding options, warrants and convertible debt. | |
CY2014Q2 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
1-for-20 reverse split | |
CY2013 | us-gaap |
Restructuring Charges
RestructuringCharges
|
1097000 | USD |
CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
17.60 | |
CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
14.55 | |
CY2013Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
6.60 | |
CY2014Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
4.67 |